Diatron Exhibits Abacus 5 and Aquila Hematology Analyzers
By LabMedica International staff writers Posted on 08 Feb 2017 |

Image: The Aquila hematology analyzer (Photo courtesy of Diatron).
Diatron, which develops, manufactures and markets hematology analyzers, and clinical chemistry analyzers, showcased its latest products, the Abacus 5 and Aquila hematology analyzers, at MEDLAB 2017, the world’s largest laboratory exhibition and congress in the Middle East.
One of the world’s top hematology analyzer manufacturers, the Hungarian company’s product range also includes hematology reagents, hematology control material, clinical chemistry analyzers, clinical chemistry reagents, and clinical chemistry controls.
At MEDLAB 2017, held at the Dubai International Convention & Exhibition Centre, UAE, from February 6-9, 2017, Diatron showcased the most advanced model in its range of hematology analyzers, the Abacus 5, which utilizes patented laser-based optical measurement technology developed by the company. The Abacus 5 provides a complete 26 parameter report, including optical determinations of the 5-part WBC differential count. It offers open and closed tube sampling options and has a throughput of 60 samples per hour in either stat or autoloader mode. The Abacus 5 hematology analyzer is one of the smallest 5-part differential analyzers available in the market and requires minimal bench space, thus making it ideal for use in space-restricted environments such as clinics and small to medium laboratories.
Diatron also exhibited Aquila, a 3-part differential hematology analyzer that can be used in any testing location and application where high quality CBC results are desired. The Diatron Aquila provides 3-part differential hematology results using less than 20 μl of whole blood and can operate in a closed or open tube mode. The system has a throughput of up to 60 tests per hour, and its compact size and unique on board reagent pack means that it requires little work and storage space. The Diatron Aquila can easily be moved from testing site to testing site and has an optional battery pack to support mobile testing needs and/or un-reliable main power supply locations.
One of the world’s top hematology analyzer manufacturers, the Hungarian company’s product range also includes hematology reagents, hematology control material, clinical chemistry analyzers, clinical chemistry reagents, and clinical chemistry controls.
At MEDLAB 2017, held at the Dubai International Convention & Exhibition Centre, UAE, from February 6-9, 2017, Diatron showcased the most advanced model in its range of hematology analyzers, the Abacus 5, which utilizes patented laser-based optical measurement technology developed by the company. The Abacus 5 provides a complete 26 parameter report, including optical determinations of the 5-part WBC differential count. It offers open and closed tube sampling options and has a throughput of 60 samples per hour in either stat or autoloader mode. The Abacus 5 hematology analyzer is one of the smallest 5-part differential analyzers available in the market and requires minimal bench space, thus making it ideal for use in space-restricted environments such as clinics and small to medium laboratories.
Diatron also exhibited Aquila, a 3-part differential hematology analyzer that can be used in any testing location and application where high quality CBC results are desired. The Diatron Aquila provides 3-part differential hematology results using less than 20 μl of whole blood and can operate in a closed or open tube mode. The system has a throughput of up to 60 tests per hour, and its compact size and unique on board reagent pack means that it requires little work and storage space. The Diatron Aquila can easily be moved from testing site to testing site and has an optional battery pack to support mobile testing needs and/or un-reliable main power supply locations.
Latest MEDLAB 2017 News
- AXA Diagnostics Showcases SkyLAB752 ELISA Analyzer
- Norma Diagnostika Showcases Icon Hematology Analyzers at MEDLAB
- AITbiotech Exhibits abTES Molecular Diagnostics Assays at MEDLAB 2017
- Binding Site Unveils Optilite Protein System
- Das SRL Exhibits New Lab Solutions at MEDLAB 2017
- Priorclave Showcases Energy-Efficient Lab Autoclaves in Dubai
- DRG Group Presents New Analyzer and ELISAs at Dubai Lab Exhibition
- Beckman Coulter Exhibits New Lab Solutions in Dubai
- Siemens Healthineers Showcases Latest Diagnostic Innovations
Channels
Clinical Chemistry
view channel
‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read moreMolecular Diagnostics
view channel
Cheap Cell-Free DNA Based Test Accurately Predicts Preterm Birth
Preterm birth (PTB) occurs in around 11% of all births globally, leading to considerable morbidity and mortality for both mothers and their newborns. Identifying pregnancies at risk of PTB early in gestation... Read more
RNA Blood Test Detects Cancers and Resistance to Treatment
A newly developed blood test offers the ability to detect cancer, understand how cancer resists treatments, and assess tissue damage from non-cancerous conditions. This innovative test, created by researchers... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read morePathology
view channel
Breakthrough Diagnostic Approach to Significantly Improve TB Detection
Tuberculosis (TB) remains the deadliest infectious disease globally, with 10.8 million new cases and 1.25 million deaths reported in 2023. Early detection through effective screening is crucial in identifying... Read more
Rapid, Ultra-Sensitive, PCR-Free Detection Method Makes Genetic Analysis More Accessible
Genetic testing has been an important method for detecting infectious diseases, diagnosing early-stage cancer, ensuring food safety, and analyzing environmental DNA. For a long time, polymerase chain reaction... Read moreTechnology
view channel
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more